Clinical trial
Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.
NCT00151645 · Rennes University Hospital, Other · Terminated
Key facts
| NCT number | NCT00151645 |
|---|---|
| Title | Efficacy of Activated Lymphocytes in Renal Cell Carcinoma. |
| Official title | Renal Cell Carcinoma Treatment With Activated Tumor- Infiltrated Lymphocytes. A Non-Randomized Phase II Trial. |
| Lead sponsor | Rennes University Hospital, Other |
| Collaborators | Ministry of Health, France |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Renal Cell Carcinoma |
| Intervention type | Drug |
| Interventions | activated lymphocytes |
| Enrollment | 36 |
| Start date | Dec 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Sep 9, 2005 |
| Last update posted | Jan 2, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: